Takeda Shores Up Pipeline Ahead Of Actos Patent Expiry
Japanese pharma also conducting an “overall re-examination” of recently halted TAK-475 cholesterol drug.
Japanese pharma also conducting an “overall re-examination” of recently halted TAK-475 cholesterol drug.